Hi NZ,
I agree with everything you said. If phase 2 is successful and we move into human trials with similar results, PAA will become a long term royalties paying hold. The only other possible outcome is a takeover by a big Pharma company, and they would need to pay a serious amount of money to get control from a small ownership base.
I have stopped trying to do evaluations because every-time I do, I sit there looking at it and thinking naw it couldn't be. We are looking at a possible disrupter here, phase 2 success in Humans may not even be the end of the story.
I'm holding tight, 22c will only be a start.
All the best
Pete
GLTAH
Hi NZ, I agree with everything you said. If phase 2 is...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $87.55M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $36.85K | 205.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 162181 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 412357 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |